{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:00:45Z","timestamp":1760385645150},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Gentamicin pharmacokinetics may be altered in pediatric patients undergoing extracorporeal membrane oxygenation (ECMO). Description of gentamicin pharmacokinetics and relevant variables can improve dosing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A retrospective population pharmacokinetic study was designed, and pediatric patients who received gentamicin while undergoing ECMO therapy over a period of 6 1\/2 years were included. Data collection included the following: patient demographics, serum creatinine, albumin, hematocrit, gentamicin dosing and serum concentrations, urine output, and ECMO circuit parameters. Descriptive statistics were used to characterize the patient population. Population pharmacokinetic analysis was performed with NONMEM, and simulation was performed to identify empiric doses to achieve therapeutic serum concentrations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>A total of 37 patients met study criteria (75.7% male patients), with a median age of 0.17 [interquartile range (IQR) 0.12\u20130.82] years. Primary indications for ECMO included the following: congenital diaphragmatic hernia (n = 17), persistent pulmonary hypertension (n = 5), and septic shock (n = 4). Patients received a total of 117 gentamicin doses [median 1.8 (IQR 1.4\u20132.9) mg\/kg\/dose] and had 125 serum concentrations measured at a median of 22.8 (IQR 15.8\u201325.5) hours after a dose. Population pharmacokinetic analysis identified a 2-compartment model with additive error as the best fit. Covariates included the following: allometrically scaled fat-free mass on clearance, central and peripheral volume of distribution (V<jats:sub>Dcentral<\/jats:sub>and V<jats:sub>Dperipheral<\/jats:sub>), and intercompartmental clearance; serum creatinine on clearance; ultrafiltration rate on central volume of distribution. Simulation identified dosage of 4\u20135 mg\/kg\/dose every 24 hours for neonates and infants as an acceptable empiric dosing regimen. Children and adolescents had elevated trough concentrations when dosed according to traditional dosing methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Fat-free mass should be used to dose gentamicin in pediatric ECMO patients. Serum creatinine is a marker of gentamicin clearance and should be used to adjust gentamicin dosing in pediatric ECMO patients.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ftd.0000000000000547","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T21:20:57Z","timestamp":1530220857000},"page":"581-588","source":"Crossref","is-referenced-by-count":16,"title":["Population Pharmacokinetic Analysis of Gentamicin in Pediatric Extracorporeal Membrane Oxygenation"],"prefix":"10.1097","volume":"40","author":[{"given":"Brady S.","family":"Moffett","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Texas Children's Hospital;"},{"name":"Department of Pediatrics, Baylor College of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Texas Children's Hospital;"},{"name":"Department of Pediatrics, Baylor College of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Galati","sequence":"additional","affiliation":[{"name":"Texas Medical Center Library, Houston, Texas."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Akcan","family":"Arikan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200342050-00001","article-title":"Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates","volume":"42","author":"Buck","year":"2003","journal-title":"Clin Pharmacokinet."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1128\/AAC.00577-16","article-title":"Development and evaluation of a gentamicin pharmacokinetic model that facilitates opportunistic gentamicin therapeutic drug monitoring in neonates and infants","volume":"60","author":"Germovsek","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"R3-20230814","first-page":"257","article-title":"Gentamicin disposition in children with chronic renal failure","volume":"2","author":"Berry","year":"1982","journal-title":"Pediatr Pharmacol."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/INF.0b013e3181ff023e","article-title":"Altered gentamicin serum concentrations in obese pediatric patients","volume":"30","author":"Choi","year":"2011","journal-title":"Pediatr Infect Dis J."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2125.1989.tb03529.x","article-title":"Gentamicin volume of distribution as a power function of body weight","volume":"28","author":"Keller","year":"1989","journal-title":"Br J Clin Pharmacol."},{"key":"R6-20230814","first-page":"262","article-title":"Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis","volume":"2","author":"Bauer","year":"1983","journal-title":"Clin Pharm."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00007691-199308000-00001","article-title":"Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs","volume":"15","author":"Dagan","year":"1993","journal-title":"Ther Drug Monit."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PCC.0000000000000970","article-title":"The incidence of acute kidney injury and its effect on neonatal and pediatric extracorporeal membrane oxygenation outcomes: a multicenter report from the kidney intervention during extracorporeal membrane oxygenation study group","volume":"17","author":"Fleming","year":"2016","journal-title":"Pediatr Crit Care Med."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1097\/PCC.0000000000000859","article-title":"Risk factors of acute kidney injury in critically ill children","volume":"17","author":"Slater","year":"2016","journal-title":"Pediatr Crit Care Med."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/j.1875-9114.1992.tb02667.x","article-title":"Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation","volume":"12","author":"Bhatt-Mehta","year":"1992","journal-title":"Pharmacotherapy."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00006454-199008000-00007","article-title":"Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation","volume":"9","author":"Cohen","year":"1990","journal-title":"Pediatr Infect Dis J."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00002216-199101000-00006","article-title":"Pharmacokinetics of gentamicin in neonatal patients supported with extracorporeal membrane oxygenation","volume":"37","author":"Munzenberger","year":"1991","journal-title":"ASAIO Trans."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1128\/AAC.33.6.817","article-title":"Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation","volume":"33","author":"Southgate","year":"1989","journal-title":"Antimicrob Agents Chemother."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40262-015-0277-z","article-title":"Prediction of fat-free mass in children","volume":"54","author":"Al-Sallami","year":"2015","journal-title":"Clin Pharmacokinet."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1020909324909","article-title":"Commentary on significance levels for covariate effects in NONMEM","volume":"29","author":"Beal","year":"2002","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1208\/ps040427","article-title":"Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis","volume":"4","author":"Wahlby","year":"2002","journal-title":"AAPS PharmSci."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","article-title":"Diagnosing model diagnostics","volume":"82","author":"Karlsson","year":"2007","journal-title":"Clin Pharmacol Ther."},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1460-9592.2011.03536.x","article-title":"Tips and traps analyzing pediatric PK data","volume":"21","author":"Anderson","year":"2011","journal-title":"Paediatr Anaesth."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00007691-199412000-00004","article-title":"Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation","volume":"16","author":"Dodge","year":"1994","journal-title":"Ther Drug Monit."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PCC.0b013e3181b80693","article-title":"Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness","volume":"11","author":"Lopez","year":"2010","journal-title":"Pediatr Crit Care Med."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2016.6361","article-title":"Trends in obesity prevalence among children and adolescents in the United States, 1988\u20131994 through 2013-2014","volume":"315","author":"Ogden","year":"2016","journal-title":"JAMA."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/FTD.0000000000000505","article-title":"The \u201cideal\u201d body weight for pediatric gentamicin dosing in the era of obesity: a population pharmacokinetic analysis","volume":"40","author":"Moffett","year":"2018","journal-title":"Ther Drug Monit."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/INF.0b013e31821e405d","article-title":"Once-daily gentamicin in infants and children: a prospective cohort study evaluating safety and the role of therapeutic drug monitoring in minimizing toxicity","volume":"30","author":"Best","year":"2011","journal-title":"Pediatr Infect Dis J."},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/PCC.0000000000001349","article-title":"The impact of fluid overload on outcomes in children treated with extracorporeal membrane oxygenation: a multicenter retrospective cohort study","volume":"18","author":"Selewski","year":"2017","journal-title":"Pediatr Crit Care Med."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201810000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T20:32:52Z","timestamp":1720384372000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201810000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000547","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}